Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acepromazine
2. Acetazine
3. Acetopromazine
4. Acetylpromazine
5. Calmivet
6. Maleate, Acepromazine
7. Plegicil
8. Vetranquil
1. 3598-37-6
2. Anatran
3. Sedalin
4. Soprontin
5. Acetopromazine Maleate Salt
6. Acepromazine Monomaleate
7. Acetopromazine Maleate
8. 37862hp2om
9. Acepromazine Hydrogen Maleate
10. Nsc-264522
11. Acetylpromazine Maleate (1:1)
12. 2-acetyl-10-(3-(dimethylamino)propyl)phenothiazine, Maleate
13. Acepromazine D6 Maleate
14. 10-(3-(dimethylamino)propyl)phenothiazin-2-yl Methyl Ketone Maleate (1:1)
15. Dsstox_cid_27763
16. Dsstox_rid_82540
17. Ethanone, 1-(10-(3-(dimethylamino)propyl)-10h-phenothiazin-2-yl)-, (z)-2-butenedioate (1:1)
18. Dsstox_gsid_47783
19. A 23051
20. Notensil Maleate
21. Maleate Acide De L'acetyl 3-dimethylamino 3-propyl-10-phenothiazine
22. Sr-05000001648
23. Ncgc00016634-01
24. Cas-3598-37-6
25. Nsc 264522
26. Acepromazine Maleate [usan]
27. Unii-37862hp2om
28. Acepromazine Maleate [usan:usp]
29. Prestwick_888
30. Einecs 222-748-9
31. Mfcd00082473
32. 1-(10-(3-(dimethylamino)propyl)-10h-phenothiazin-2-yl)ethanone Maleate
33. (z)-but-2-enedioic Acid;1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone
34. Acepromazinemaleate
35. Acepromazine Hydrogenmaleate
36. Acepromazine Maleate (usp)
37. Schembl204733
38. Chembl1883146
39. Dtxsid6047783
40. Acepromazine Maleate [mi]
41. 2-acetyl-10-(3-dimethylaminopropyl)phenothiazine Maleate Salt
42. Hms1569d14
43. Hms2093n15
44. Hms2096d14
45. Hms3263n18
46. Hms3713d14
47. Pharmakon1600-01505498
48. Phenothiazine, 2-acetyl-10-(3-(dimethylamino)propyl)-, Maleate
49. Tox21_110536
50. Tox21_501268
51. Acepromazine Maleate [mart.]
52. Nsc760058
53. Acepromazine Maleate [usp-rs]
54. Acepromazine Maleate [who-dd]
55. Akos015855868
56. Maleate Acide De L'acetyl 3-dimethylamino 3-propyl-10-phenothiazine [french]
57. Tox21_110536_1
58. Acepromazine Maleate, >=98% (hplc)
59. Ccg-213470
60. Ds-9727
61. Nsc-760058
62. Acepromazine Maleate [green Book]
63. Ncgc00016634-04
64. Ncgc00261953-01
65. Acepromazine Maleate [usp Monograph]
66. Cs-0013292
67. Acepromazine Maleate 100 Microg/ml In Ethanol
68. D02604
69. 9-oxo-9h-thioxanthene-3-carboxylicacid&
70. A874474
71. A935720
72. Sr-05000001648-1
73. Sr-05000001648-2
74. Q27256656
75. Acepromazine Maleate, United States Pharmacopeia (usp) Reference Standard
76. Ketone, 10-(3-(dimethylamino)propyl)phenothiazin-2-yl Methyl, Maleate (1:1)
77. (2z)-but-2-enedioic Acid; 1-{10-[3-(dimethylamino)propyl]-10h-phenothiazin-2-yl}ethan-1-one
78. 115120-92-8
Molecular Weight | 442.5 g/mol |
---|---|
Molecular Formula | C23H26N2O5S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 7 |
Exact Mass | 442.15624311 g/mol |
Monoisotopic Mass | 442.15624311 g/mol |
Topological Polar Surface Area | 123 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 533 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5177
Submission : 1983-11-04
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7803
Submission : 1988-11-28
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7803
Submission : 1988-11-28
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5177
Submission : 1983-11-04
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 60592-430
Start Marketing Date : 2020-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54154-019
Start Marketing Date : 2010-03-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54154-028
Start Marketing Date : 2024-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
VMF Number : 3724
Submission : 1978-10-03
Status : Active
Type : II
VMF Number : 3725
Submission : 1978-10-03
Status : Active
Type : II
VMF Number : 5684
Submission : 2000-08-08
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 6631-94-3
End Use API : Acepromazine
About The Company : Anupam Rasayan India Limited was started in 1976 and we are 36 years old. ISO 9001:2008 and ISO 14001:2004 certified chemical company with sound technology, en...
3-DIMETHYL AMINO PROPYL CHLORIDE HCL 65%
CAS Number : 5407-04-5
End Use API : Acepromazine
About The Company : Atom pharma is ISO 9001:2015 integrated, fastest growing and reputed Pharmaceutical bulk drugs [API] and pharmaceutical Intermediates exporting company. We have...
CAS Number : 6631-94-3
End Use API : Acepromazine
About The Company : With nearly seven decades of manufacturing expertise, Speichim Processing actively formulates circular economy strategies by reclaiming waste and chemical produ...
Regulatory Info :
Registration Country : Canada
Brand Name : ATRAVET 10 MG INJECTABLE
Dosage Form : SOLUTION
Dosage Strength : 10MG/ML
Packaging : 50 ML
Approval Date :
Application Number : 53023
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : ACEVET 25 INJECTABLE
Dosage Form : SOLUTION
Dosage Strength : 25MG/ML
Packaging : 100ML
Approval Date :
Application Number : 526061
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country :
Brand Name : Equipromazina
Dosage Form :
Dosage Strength : 5MG/ML
Packaging : 25 & 100 ML Vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Packaging : 25 & 100 ML Vial
Regulatory Info :
Dosage :
Dosage Strength : 5MG/ML
Brand Name : Equipromazina
Approval Date :
Application Number :
Registration Country :
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Acepromazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acepromazine, including repackagers and relabelers. The FDA regulates Acepromazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acepromazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Acepromazine supplier is an individual or a company that provides Acepromazine active pharmaceutical ingredient (API) or Acepromazine finished formulations upon request. The Acepromazine suppliers may include Acepromazine API manufacturers, exporters, distributors and traders.
click here to find a list of Acepromazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Acepromazine DMF (Drug Master File) is a document detailing the whole manufacturing process of Acepromazine active pharmaceutical ingredient (API) in detail. Different forms of Acepromazine DMFs exist exist since differing nations have different regulations, such as Acepromazine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Acepromazine DMF submitted to regulatory agencies in the US is known as a USDMF. Acepromazine USDMF includes data on Acepromazine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Acepromazine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Acepromazine suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Acepromazine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Acepromazine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Acepromazine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Acepromazine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Acepromazine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Acepromazine suppliers with NDC on PharmaCompass.
Acepromazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acepromazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acepromazine GMP manufacturer or Acepromazine GMP API supplier for your needs.
A Acepromazine CoA (Certificate of Analysis) is a formal document that attests to Acepromazine's compliance with Acepromazine specifications and serves as a tool for batch-level quality control.
Acepromazine CoA mostly includes findings from lab analyses of a specific batch. For each Acepromazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acepromazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Acepromazine EP), Acepromazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acepromazine USP).
LOOKING FOR A SUPPLIER?